Login / Signup

The ERS-endorsed official ATS/CDC/IDSA clinical practice guidelines on treatment of drug-susceptible tuberculosis.

Giovanni SotgiuPayam NahidRobert LoddenkemperIbrahim AbubakarMarc MiravitllesGiovanni Battista Migliori
Published in: The European respiratory journal (2016)
Keyphrases
  • adverse drug
  • cell cycle
  • hiv aids
  • pulmonary tuberculosis
  • cell proliferation
  • combination therapy
  • human immunodeficiency virus
  • hiv infected
  • antiretroviral therapy